Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-028775
Filing Date
2021-02-04
Accepted
2021-02-04 16:01:20
Documents
61
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q d109214d10q.htm 10-Q 464769
2 EX-31.1 d109214dex311.htm EX-31.1 10732
3 EX-31.2 d109214dex312.htm EX-31.2 10735
4 EX-32.1 d109214dex321.htm EX-32.1 5508
11 GRAPHIC g109214page22a.jpg GRAPHIC 24556
12 GRAPHIC g109214page25a.jpg GRAPHIC 11145
13 GRAPHIC g109214page25b.jpg GRAPHIC 16538
  Complete submission text file 0001193125-21-028775.txt   4012435

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20201231.xml EX-101.INS 808898
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20201231.xsd EX-101.SCH 40413
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20201231_cal.xml EX-101.CAL 33416
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20201231_def.xml EX-101.DEF 261541
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20201231_lab.xml EX-101.LAB 349175
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20201231_pre.xml EX-101.PRE 302931
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 21591050
SIC: 2834 Pharmaceutical Preparations